A Study of AMG 557 in Adults With Systemic Lupus Erythematosus

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

AMG 557

A total of 4 cohorts will be administered multiple doses of drug or placebo subcutaneously. Dose escalation will take place by cohort.

Trial Locations (12)

11030

Research Site, Manhasset

14642

Research Site, Rochester

16635

Research Site, Duncansville

33143

Research Site, Miami

36207

Research Site, Anniston

46360

Research Site, Michigan City

75231

Research Site, Dallas

79124

Research Site, Amarillo

85013

Research Site, Phoenix

94578

Research Site, San Leandro

06810

Research Site, Danbury

L3Y 3R7

Research Site, Newmarket

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY